PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Jan-2026 Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan Businesswire
08-Jan-2026 Transcat Announces Executive Equity Retention Awards Ahead of CEO Succession in FY2026 Businesswire
08-Jan-2026 Cellarity Provides Strategic Priorities and Outlook for 2026 Businesswire
08-Jan-2026 Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD Businesswire
08-Jan-2026 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer Businesswire
08-Jan-2026 INTENT Biologics Receives FDA Fast Track Designation for PEP Biologicâ„¢ Businesswire
08-Jan-2026 Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit Businesswire
08-Jan-2026 Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development Businesswire
08-Jan-2026 Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease Businesswire
08-Jan-2026 Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases Businesswire
08-Jan-2026 Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook Businesswire
08-Jan-2026 Osel Enters Agreement with SWOG Cancer Research Network for First-Ever Pivotal Trial of a Microbiome-Based Therapy in Oncology Businesswire
08-Jan-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
08-Jan-2026 FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference Businesswire
08-Jan-2026 4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics Businesswire
08-Jan-2026 Antin to Acquire Emsere, a Global Leader in Clinical Trial Equipment Infrastructure Businesswire
08-Jan-2026 Novotech Appoints Anand Tharmaratnam as New CEO Businesswire
08-Jan-2026 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
08-Jan-2026 Aptar Announces 2026 Quarterly Conference Call Dates Businesswire
08-Jan-2026 Renowned Attorney Mark Lanier Inducted into Lawdragon Leading Lawyers Hall of Fame Businesswire